SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-072531
Filing Date
2024-06-12
Accepted
2024-06-12 17:00:12
Documents
12
Period of Report
2024-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20240607.htm   iXBRL 8-K 43057
2 EX-10.1 rnlx-ex10_1.htm EX-10.1 93595
  Complete submission text file 0000950170-24-072531.txt   308586

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240607.xsd EX-101.SCH 51220
16 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240607_htm.xml XML 5900
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 241039100
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)